• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂毒性途径在肝细胞中交汇:内质网应激、c-Jun N-末端激酶-1 和死亡受体。

Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors.

机构信息

Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki City, Japan.

出版信息

Hepatol Res. 2016 Sep;46(10):977-84. doi: 10.1111/hepr.12658. Epub 2016 Apr 15.

DOI:10.1111/hepr.12658
PMID:26938481
Abstract

Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly more common worldwide. Hepatocyte apoptosis caused by free fatty acids, termed hepatocyte lipoapoptosis, is a feature of non-alcoholic steatohepatitis (NASH), an advanced form of NAFLD. As no salutary treatment for NASH exists, it is important to understand the molecular mechanisms responsible for disease development and progression. This review discusses recent developments in research on hepatocyte lipoapoptosis, focusing on the endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptor-mediated pathway networks and their modulators and interactions. In addition, we describe the emerging importance of the signaling pathways that not only impact the dying hepatocytes themselves, but also influence surrounding cells and possibly promote disease progression through the release of microvesicles. Overall, a more comprehensive understanding of the molecular mediators in lipotoxicity-related pathways would likely benefit the development of mechanism-based therapies of NASH.

摘要

非酒精性脂肪性肝病(NAFLD)在全球范围内变得越来越普遍。由游离脂肪酸引起的肝细胞凋亡,称为肝细胞脂肪凋亡,是一种非酒精性脂肪性肝炎(NASH)的特征,NASH 是一种更高级的 NAFLD 形式。由于目前尚无治疗 NASH 的有效方法,因此了解导致疾病发展和进展的分子机制非常重要。这篇综述讨论了肝细胞脂肪凋亡研究的最新进展,重点介绍了内质网应激、c-Jun N 末端激酶-1 和死亡受体介导的途径网络及其调节剂和相互作用。此外,我们还描述了信号通路的重要性不断增加,这些信号通路不仅影响垂死的肝细胞本身,还影响周围细胞,并可能通过释放微泡促进疾病进展。总的来说,更全面地了解与脂肪毒性相关途径中的分子介质可能有助于开发 NASH 的基于机制的治疗方法。

相似文献

1
Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors.脂毒性途径在肝细胞中交汇:内质网应激、c-Jun N-末端激酶-1 和死亡受体。
Hepatol Res. 2016 Sep;46(10):977-84. doi: 10.1111/hepr.12658. Epub 2016 Apr 15.
2
Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病
Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.
3
To die or not to die: death signaling in nonalcoholic fatty liver disease.生死抉择:非酒精性脂肪性肝病中的死亡信号。
J Gastroenterol. 2018 Aug;53(8):893-906. doi: 10.1007/s00535-018-1451-5. Epub 2018 Mar 24.
4
Decoding cell death signals in liver inflammation.解析肝炎症中的细胞死亡信号。
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.
5
Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.减轻的脂毒性和细胞凋亡通过不同途径与肝脏再生的外源性和内源性增强剂相关联。
PLoS One. 2017 Sep 6;12(9):e0184282. doi: 10.1371/journal.pone.0184282. eCollection 2017.
6
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.非酒精性脂肪性肝炎的发病机制:营养过剩的代谢并发症如何导致脂毒性和促炎脂肪性肝病。
Adv Exp Med Biol. 2018;1061:19-44. doi: 10.1007/978-981-10-8684-7_3.
7
Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis.丙型肝炎病毒感染增加 c-Jun N-末端激酶(JNK)磷酸化并加重肝细胞脂肪凋亡。
Med Sci Monit. 2017 Sep 21;23:4526-4532. doi: 10.12659/msm.903210.
8
Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.腺苷 A(2a)受体刺激可预防大鼠肝细胞脂肪毒性和非酒精性脂肪性肝炎(NASH)。
Clin Sci (Lond). 2012 Sep;123(5):323-32. doi: 10.1042/CS20110504.
9
Apoptosis and non-alcoholic fatty liver diseases.细胞凋亡与非酒精性脂肪性肝病。
World J Gastroenterol. 2018 Jul 7;24(25):2661-2672. doi: 10.3748/wjg.v24.i25.2661.
10
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.肉豆蔻酸通过持续从头合成神经酰胺,增强棕榈酸诱导的与脂肪营养不良相关的脂毒性和脂肪性肝炎。
Oncotarget. 2015 Dec 8;6(39):41479-96. doi: 10.18632/oncotarget.6286.

引用本文的文献

1
Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).LXR-LPCAT3 信号通路中磷脂代谢的研究进展、挑战和展望及其与 NAFLD 的关系(综述)。
Int J Mol Med. 2024 Apr;53(4). doi: 10.3892/ijmm.2024.5356. Epub 2024 Feb 16.
2
The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective.脂滴在衰老中的双面角色:来自细胞视角的见解。
Biomolecules. 2023 May 30;13(6):912. doi: 10.3390/biom13060912.
3
Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
克罗恩病与非酒精性脂肪性肝病患者的肝纤维化相关。
Dig Dis Sci. 2023 Mar;68(3):1006-1015. doi: 10.1007/s10620-022-07562-0. Epub 2022 Jun 22.
4
Liver Steatosis: A Marker of Metabolic Risk in Children.肝脂肪变性:儿童代谢风险的标志物。
Int J Mol Sci. 2022 Apr 27;23(9):4822. doi: 10.3390/ijms23094822.
5
A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies.AMPK 在非酒精性脂肪性肝病从头合成脂肪中的作用的叙事性综述:来自人体研究的证据。
Cells. 2021 Jul 19;10(7):1822. doi: 10.3390/cells10071822.
6
Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.靶向代谢相关脂肪性肝病(MAFLD)中程序性细胞死亡:一种有前途的新疗法。
Cell Mol Biol Lett. 2021 May 7;26(1):17. doi: 10.1186/s11658-021-00254-z.
7
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?肝内脂质堆积如何导致非酒精性脂肪性肝病的脂毒性?
Hepatol Int. 2021 Feb;15(1):21-35. doi: 10.1007/s12072-020-10121-2. Epub 2021 Feb 6.
8
Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model.发酵人参GBCK25可改善非酒精性脂肪性肝炎模型中的脂肪变性和炎症。
J Ginseng Res. 2019 Apr;43(2):196-208. doi: 10.1016/j.jgr.2017.10.002. Epub 2017 Oct 21.
9
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.肝巨噬细胞在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的作用。
Lab Anim Res. 2018 Dec;34(4):133-139. doi: 10.5625/lar.2018.34.4.133. Epub 2018 Dec 31.
10
Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches.非酒精性脂肪性肝炎的发病机制及基于激素的治疗方法。
Front Endocrinol (Lausanne). 2018 Aug 24;9:485. doi: 10.3389/fendo.2018.00485. eCollection 2018.